Men

Haemochromatosis  Autosomal recessive  Excessive iron accumulation  0.5% of the Caucasians  Woman usually present a decade later than men due to menstrual …  

DNA tests, like those for women's breast cancer, could soon be used to see which men face the highest risk of deadly prostate cancer, scientists say.  

At the NYAS March 2011 Music, Science and Medicine conference, Assistant Professor of Psychiatry and Neuroscience at Mount Sinai School of Medicine and 2010 Blavatnik Award winner, Daniela Schiller, talks to Roger Bingham about how she got into science and reviews research in modifying fear memories.  

A pneumothorax is a collection of air in the pleural space. They can be: Primary – no underlying lung disease. Typically, tall thin young men might have a spontaneous pneumothorax Secondary – to underlying lung disease   They can be divided into: Standard pneumothorax  

Links to brief synopsis of Multiple Endocrine Neoplasia on almostadoctor.co.uk  

Faecal incontinence Occurs in 15% aged >65Y, increasing incidence with age in men only. Causes include: Sphincter weakness (following childbirth/surgery); Anal/rectal pathology e.g. fistulae, Crohn’s, proctitis;  

Remember, although rare, men can also get breast cancer. Less than 1% of breast cancers occur in men. Benign breast masses are 15x more common than breast cancer   Epidemiology In the UK, a woman has a 1/9 chance of developing breast cancer It is the most common cause of death in women aged 35-55  

Sterilisation Can be controversial in some cultures Should only be undertaken in stable relationships where the couple is certain they do not want any more children   Epidemiology Rates falling in developed countries UK is unusual as the number of men receiving the operation is greater than the number of women 18% of men between 18-69 have had a vasectomy  

This is a parasitic protozoan infection, the result of infection with the flagellated anaerobic trichomonas vaginalis. This is the most common protozoan infection in the developed world It is a sexually transmitted infection although men are usually asymptomatic.   Epidemiology  

  By the age of 80, >80% of men have prostate cancer It is the second most common cancer in men, and the 4th most common cause of death for men in England and Wales. Rates of prostate cancer are particularly low in Asians, and particularly high in African Americans and Scandinavians. The tumours are adenomas and are usually located in the peripheral prostate.  

Generalised Anxiety Disorder (GAD) Epidemiology Very common. Prevalence: Men – 2-4% Women 3-4.5% Accounts for 1/3 of all psychiatric diagnosis Accounts for 10% of all GP consultations Closely related to depression – and many patients move between the two states. Often patients satisfy the criteria for both anxiety and depression  

Fear disorders; Panic, Phobia and PTSD It is often hard to distinguish what is ‘normal’ fear, and what classifies as a psychiatric diagnosis. In practice, often these patients have symptoms of anxiety and fear, and diagnosis from GAD may be difficult.   Epidemiology Affect 3% of men and 6% of women Long duration   Aetiology  

Young men with an eating disorder are not getting the help and support they need because of perceptions about a "women's illness", say researchers.  

Deaths from pancreatic cancer are predicted to increase in men and women while rates for all other cancers, except lung cancer in women, continue to decrease, says an analysis of current trends across European countries published this week.1  

Few healthcare issues have generated as much controversy as prostate specific antigen (PSA) based screening for prostate cancer.1 2 Enthusiasm for such screening is high in part because a seemingly simple blood test can lead to early detection and treatment of a common and potentially lethal disease. Screening has resulted in a noticeable increase in incidence of prostate cancer and near universal active treatment for screen detected disease. However, recent science shows that screening for prostate cancer, as with all screening strategies, is a complex process and double-edged sword. This provides the background for the linked paper by Carlsson and colleagues (doi:10.1136/bmj.g2296).3 Though some men may benefit from screening, many more are harmed by testing and the cascade of diagnostic and treatment related events that follow. Further, men and society bear the financial costs of this screening cascade.  

Men with early prostate cancer who are treated with androgen deprivation therapy instead of surgery or radiation therapy show no reduction in mortality compared with those who receive no treatment, a retrospective analysis of US cancer registries has shown.1  

Few healthcare issues have generated as much controversy as prostate specific antigen (PSA) based screening for prostate cancer.1 2 Enthusiasm for such screening is high in part because a seemingly simple blood test can lead to early detection and treatment of a common and potentially lethal disease. Screening has resulted in a noticeable increase in incidence of prostate cancer and near universal active treatment for screen detected disease. However, recent science shows that screening for prostate cancer, as with all screening strategies, is a complex process and double-edged sword. This provides the background for the linked paper by Carlsson and colleagues (doi:10.1136/bmj.g2296).3 Though some men may benefit from screening, many more are harmed by testing and the cascade of diagnostic and treatment related events that follow. Further, men and society bear the financial costs of this screening cascade.